Wellington Management Group LLP Boosts Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Wellington Management Group LLP increased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 517.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 175,152 shares of the medical device company's stock after acquiring an additional 146,771 shares during the period. Wellington Management Group LLP owned about 0.09% of Cooper Companies worth $16,102,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in Cooper Companies during the fourth quarter valued at about $691,000. Caprock Group LLC bought a new position in shares of Cooper Companies in the fourth quarter worth about $282,000. Entropy Technologies LP bought a new position in shares of Cooper Companies in the fourth quarter worth about $248,000. Lecap Asset Management Ltd. boosted its stake in shares of Cooper Companies by 33.1% in the fourth quarter. Lecap Asset Management Ltd. now owns 11,955 shares of the medical device company's stock worth $1,099,000 after acquiring an additional 2,974 shares during the period. Finally, Apollon Wealth Management LLC bought a new position in shares of Cooper Companies in the fourth quarter worth about $200,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

NASDAQ COO traded up $3.76 during trading hours on Thursday, reaching $71.18. The company's stock had a trading volume of 5,056,066 shares, compared to its average volume of 1,579,597. The firm has a market capitalization of $14.23 billion, a price-to-earnings ratio of 36.50, a P/E/G ratio of 2.25 and a beta of 0.98. The Cooper Companies, Inc. has a 1-year low of $65.00 and a 1-year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company's 50-day moving average is $78.53 and its two-hundred day moving average is $87.57.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies's quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.85 EPS. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

COO has been the subject of a number of recent analyst reports. Wells Fargo & Company dropped their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research note on Friday, May 30th. Citigroup dropped their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a research note on Friday, May 30th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, BNP Paribas raised Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of "Moderate Buy" and an average target price of $100.38.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.